132 related articles for article (PubMed ID: 32008443)
1. Effectively managing an IP portfolio? Not an easy task.
Pontremoli G
Pharm Pat Anal; 2020 Jan; 9(1):7-8. PubMed ID: 32008443
[No Abstract] [Full Text] [Related]
2. Patent portfolio management: literature review and a proposed model.
Conegundes De Jesus CK; Salerno MS
Expert Opin Ther Pat; 2018 Jun; 28(6):505-516. PubMed ID: 29718747
[TBL] [Abstract][Full Text] [Related]
3. Getting the most out of your IP--patent management along its life cycle.
Bader MA; Gassmann O; Ziegler N; Ruether F
Drug Discov Today; 2012 Apr; 17(7-8):281-4. PubMed ID: 22079191
[TBL] [Abstract][Full Text] [Related]
4. IP issues facing researchers by Gino D'Oca.
Almarsson O; Angiolini M; Baell J; Giardina G; Ingham A; Hughes A; Pevarello P; Sindelar R
Pharm Pat Anal; 2012 May; 1(2):129-35. PubMed ID: 24236778
[TBL] [Abstract][Full Text] [Related]
5. Patent quality.
Sklan A
Pharm Pat Anal; 2014 Jan; 3(1):17-24. PubMed ID: 24354975
[TBL] [Abstract][Full Text] [Related]
6. Patent law protection of inventions in medicine and pharmaceutical industry.
Miladinović Z; Varga S; Radojković M
Vojnosanit Pregl; 2013 Jun; 70(6):600-5. PubMed ID: 23885528
[No Abstract] [Full Text] [Related]
7. Pharmaceutical patent law: expert perspectives from around the globe.
Komatani TS
Pharm Pat Anal; 2016 Jul; 5(4):195-7. PubMed ID: 27409277
[No Abstract] [Full Text] [Related]
8. Patent portfolios for biotech inventions.
Wang SJ
Nat Biotechnol; 2013 Jun; 31(6):501-3. PubMed ID: 23752433
[No Abstract] [Full Text] [Related]
9. Which patent and where? Why international patent transparency by companies is needed for medicines.
Beall RF; Attaran A
Nat Biotechnol; 2016 Sep; 34(9):923-6. PubMed ID: 27606455
[No Abstract] [Full Text] [Related]
10. China tightens IP protection, but concerns linger.
Jia H
Nat Biotechnol; 2009 Sep; 27(9):787-8. PubMed ID: 19741619
[No Abstract] [Full Text] [Related]
11. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
Xu Z; Chen W
Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
[TBL] [Abstract][Full Text] [Related]
12. Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP; Deng MM
Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
[No Abstract] [Full Text] [Related]
13. Patent-free pact pushes the boundaries of precompetitive research.
Dolgin E
Nat Med; 2014 Jun; 20(6):564-5. PubMed ID: 24901552
[No Abstract] [Full Text] [Related]
14. Applying a gaming approach to IP strategy.
Gasnier A; Vandamme L
IDrugs; 2010 Feb; 13(2):97-102. PubMed ID: 20127561
[TBL] [Abstract][Full Text] [Related]
15. U.S. patent law. Case probes what's fair game in the search for new drugs.
Kintisch E
Science; 2005 Apr; 308(5719):174. PubMed ID: 15821048
[No Abstract] [Full Text] [Related]
16. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
Jannuzzi AH; Vasconcellos AG; de Souza CG
Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
[TBL] [Abstract][Full Text] [Related]
17. Intellectual property protection: strategies for antibody inventions.
Storz U
MAbs; 2011; 3(3):310-7. PubMed ID: 21494091
[TBL] [Abstract][Full Text] [Related]
18. International intellectual property strategies for therapeutic antibodies.
Storz U
MAbs; 2011; 3(6):596-606. PubMed ID: 22123063
[TBL] [Abstract][Full Text] [Related]
19. Undermining TRIPS: protectionism at its worst.
Lancet; 2007 Jan; 369(9555):2. PubMed ID: 17208619
[No Abstract] [Full Text] [Related]
20. [SCHWABE Company's patent portfolio of Ginkgo biloba preparation].
Liu W; Cheng XM; Geng DM; Tan W; Zou WJ
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3384-8. PubMed ID: 25522634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
